Identification and multi-omics analysis of extracellular vesicles from the plerocercoids of Spirometra mansoni (Cestoda: Diphyllobothriidae) Authors: Xuan Xuan Song, Fei Gao, Gu Jin Guan, Yan Yan Zhou, Xi Zhang Published: 2026 ABSTRACT AbstractParasitic extracellular vesicles (EVs) play crucial roles in the growth and development of parasites. However, we remain unaware of the EVs from the plerocercoids of Spirometra mansoni. In this study, firstly, the plerocercoids of S. mansoni were cultured in vitro to enrich EVs, which were then characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. Next, the protein components and miRNAs of EVs were subsequently analysed using data-independent acquisition (DIA) and high-throughput sequencing, respectively. The results showed that EVs derived from the plerocercoids exhibit a typical double-layered membrane structure as spherical or elliptical vesicles ranging from 80 to 150 nm in diameter. The molecular markers HSP70, TSG101, HSP90, CD81, and β-Actin were significantly expressed in these EVs. Micro-proteomic analysis revealed 2,729 proteins, with functional annotation indicating that EV proteins are enriched primarily in pathways such as intracellular transport/secretion, cellular processes, and signal transduction. High-throughput miRNA sequencing revealed that the identified EVs contained 37 known miRNAs and 118 novel miRNAs. Functional enrichment analysis indicated that miRNAs primarily participate in host interactions by regulating DNA integration, apoptosis, cholesterol metabolism, and cAMP signaling pathways. Immunological analysis demonstrated that the antiserum against EVs elicited a mixed Th1/Th2 immune response, which was predominantly Th1-type. In this study, S. mansoni plerocercoid-derived EVs were successfully isolated and characterized. Systematic profiling of EV components via microproteomics and high-throughput miRNA sequencing provides a foundation for further investigations into the functional mechanisms of EVs.Supplementary InformationThe online version contains supplementary material available at 10.1007/s00436-026-08710-5.Keywords: Spirometra mansoni, Plerocercoid, Extracellular vesicles, Proteomics, miRNA Introduction Zoonotic taeniasis poses serious threats to human health and socioeconomic well-being (Grecco et al. 2023). However, research on some zoonotic tapeworms, such as Spirometra mansoni, remains limited (Xu et al. 2022; Zhang et al. 2020). The plerocercoids of S. mansoni can parasitize human tissues and organs, causing severe larva migrans, which may lead to blindness, paralysis, or even death (Kuchta et al. 2021; Zhou et al. 2025). This disease is widely distributed and is particularly prevalent in East and Southeast Asia (Liu et al. 2015; 2022). Currently, clinical diagnosis primarily relies on invasive biopsy of the parasite. However, due to factors such as low parasite burden and deep-seated infection sites (e.g., the central nervous system), this method is often difficult to implement (Li et al. 2025). There is an urgent need for highly sensitive auxiliary diagnostic methods. Serological diagnosis serves as a useful adjunctive method; however, current serological diagnostic approaches are limited in accuracy due to the lack of highly specific antigens, making them prone to cross-reactivity. In recent years, EVs secreted by parasites, due to their rich content of proteins, nucleic acids, and other bioactive components, have emerged as important research targets for discovering novel diagnostic biomarkers and elucidating the mechanisms of host-parasite interactions (Ancarola et al. 2017; Barnadas-Carceller et al. 2024; Mu et al. 2021). As key mediators of intercellular communication, EVs can deliver functional molecules into host cells, thereby regulating their growth, proliferation, differentiation, and apoptosis (Cortés et al. 2025; Wortzel et al. 2019). On the basis of their origin, composition, and biogenesis, extracellular vesicles can be classified into the following types: exosomes, microvesicles (MVs), and apoptotic bodies (Abs) (Ma et al. 2015), and, more recently recognized, supermeres, nanomeres, and exomeres. The latter three are emerging EV subtypes that are extremely small in size and possess high tissue-penetrating capability; they carry unique molecular cargoes and may mediate specialized intercellular communication functions (Jeppesen et al. 2023). Furthermore, Exosomes are uniform vesicle-like structures with diameters ranging from 40 to 100 nm. They function as carriers for signal molecule transmission; they not only mediate macromolecular communication between cells but also facilitate the regulation and transport of lipids, proteins, and mRNAs and contribute to disease progression (Berumen Sánchez et al. 2021). MVs are heterogeneous vesicles ranging from 100 to 1000 nm in diameter that are generated directly from the cell membrane. They participate in the regulation of cellular functions by influencing signal transduction pathways (Ashoub et al. 2024). Abs, measuring 50 ~ 5000 nm in diameter, are vacuoles formed during late apoptosis. They mediate intercellular communication and play a crucial role in maintaining homeostasis (Miao et al. 2024). Studies have shown that parasite-derived EVs typically range from 40 to 100 nm in diameter, and they fuse with the membrane of target cells by binding to surface receptors, releasing their contents into host cells (Jadli et al. 2020). This process enables the transmission of virulence factors, interferes with host immune responses, and regulates the inflammatory environment. Additionally, EVs regulate host gene expression by exporting miRNAs (Drurey and Maizels 2021). EVs mediate intercellular communication to regulate host-parasite interactions, aiding parasites in evading host immune attacks to sustain parasitism. This significantly affects parasite growth, development, and disease progression (Ofir-Birin and Regev-Rudzki 2019; Pinheiro et al. 2024). In recent years, significant progress has been made in the study of tapeworm-derived EVs. For instance, EV-derived miRNAs from Echinococcus granulosus can regulate the protoscolex encystment process (Gao J et al. 2022). EVs derived from Taenia solium cysticerci possess immunomodulatory and therapeutic potential, providing a theoretical basis for developing new strategies (Rawat et al. 2024). EVs from Echinococcus multilocularis can regulate macrophage polarization via specific miRNAs, thereby influencing the immune microenvironment (Xin et al. 2025). These advances demonstrate that in-depth analysis of the composition and function of cestode EVs can not only provide novel diagnostic targets but also contribute to understanding infection mechanisms and developing new intervention strategies. However, despite the promising prospects of EV research, studies on the composition and function of EVs derived from plerocercoids of S. mansoni remain completely absent. To fill this knowledge gap, this study, for the first time, isolates and characterizes EVs from plerocercoids of S. mansoni and systematically analyzes their core molecular composition by integrating DIA quantitative proteomics with high-throughput miRNA sequencing. This work aims to lay a foundation for the subsequent development of novel diagnostic methods and in-depth functional mechanistic studies. Materials and methods Parasites and experimental animals Plerocercoids were isolated from naturally infected Zaocys dhumnades in Changsha city, Hunan Province, China. Plerocercoids were identified as S. mansoni on the basis of molecular genotyping as described by Kuchta et al. (Kuchta et al. 2021). The isolated plerocercoids were washed with PBS, and the scolex was dissected. The scolex was orally administered to 6–8-week-old female KunMing (KM) mice (3 plerocercoids per mouse). After one month, the scolices developed into complete adult worms, enabling laboratory conservation and successive passages (Liu et al. 2025). Both 4–6-week-old female BALB/c mice and 6–8-week-old female KM mice were purchased from the Henan Provincial Experimental Animal Center. The flowchart of this study is shown in Fig. 1. Workflow of the characterization and multi-omics analysis of plerocercoid EVs. It constructed using BioGDP.com (Jiang et al. 2025) Extraction of EVs from plerocercoids The plerocercoids were washed three times with PBS containing dual antibiotics (100 U/mL penicillin and 100 µg/mL streptomycin), followed by three washes with serum-free RPMI 1640 medium containing dual antibiotics. Plerocercoids were cultivated in prewarmed, serum-free RPMI 1640 medium supplemented with dual antibiotics at 37 °C and 5% CO₂. The medium was replaced every 24 h, and all culture supernatants were collected continuously for two weeks. During the culture period, the viability of the plerocercoids was observed daily under a microscope. The survival criteria were defined as active autonomous movement (such as stretching and wriggling) and an intact, smooth tegument without damage or autolysis. Only medium from plerocercoids that maintained good viability throughout was used for EVs collection. Subsequently, the culture supernatant was filtered through a 0.22 μm sterile filter to remove bacteria, then the filtrate was centrifuged at 4 °C and 120,000 × g for 2 h using a Beckman L-100 K ultracentrifuge. The supernatant was discarded, and the EVs-enriched pellet was resuspended in 100 µL of sterile PBS and stored at −80 °C for future use. Transmission electron microscopy (TEM) analysis Approximately 20 µL of sample was dispensed onto the sample plate. The copper mesh was placed face-down over the droplet surface. After 3 min, it was removed and the sample was air-dried at room temperature. The mesh was placed face-down in a 2% phosphotungstic acid staining solution for 2 min. The copper mesh was removed, and the excess staining solution was blotted with filter paper. Image acquisition of the copper mesh was performed using a JEM-1400FLASH transmission electron microscope (JEOL Ltd., Japan) to observe the specific morphology of the EVs. Nanoparticle tracking analysis (NTA) The EVs-enriched PBS solution stored at −80 °C was thawed on ice, and the original particle concentration of the sample was first determined by NTA. To meet the optimal detection requirements of the NTA instrument, the dilution ratio was calculated using the dilution formula C₁V₁ = C₂V₂ (where C₁ is the particle concentration of the stock solution, V₁ is the volume of the stock solution, C₂ is the concentration after dilution, and V₂ is the total volume after dilution). Pre-cooled 1× PBS was used for dilution to precisely adjust the particle concentration of the sample to 10⁶–10⁸ particles/mL. The diluted sample was then analyzed using a PMX120 NTA instrument (Particle Metrix, Germany) to determine the size distribution of the EVs. Western blot analysis The frozen EVs solution was thawed and lysed with pre-cooled RIPA lysis buffer (Solarbio, Beijing) on ice for 30 min, followed by centrifugation at 12,000 × g for 15 min at 4 °C. The supernatant containing EV proteins was collected. Subsequently, the EVs protein solution was mixed with 5× loading buffer at a 1:5 ratio, boiled for denaturation, and then separated on a 12% SDS-PAGE gel. A total of 15 µg protein was loaded per well. Electrophoresis was performed initially at 80 V for 30 min, after which the voltage was adjusted to 120 V and continued until the bromophenol blue dye reached the bottom of the gel. Proteins were transferred using a wet transfer system with 1× transfer buffer at a constant current of 250 mA for 90 min. After transfer, the PVDF membrane was blocked with TBST buffer containing 5% skimmed milk powder. Subsequently, the membrane was incubated overnight at 4 °C with primary antibodies. The primary antibodies used were rabbit monoclonal antibodies against HSP70, β-Actin, TSG101, HSP90, and CD81 (1:200; Abmart, Shanghai). After washing, the membrane was incubated with an HRP-conjugated secondary antibody on a shaker at 37 °C for 1 h. The secondary antibody was HRP-labeled goat anti-rabbit IgG (1:5000, Boster, Hubei). Finally, the membrane was incubated in the dark with a freshly prepared ECL substrate solution and imaged using a Tanon gel imaging system (Tanon, Shanghai). Protein extraction and peptide sample preparation Using the Majorbio Microprotein Kit (Majorbio, shanghai), proteins were extracted from EVs according to the protocol instructions. The specific steps were as follows: An appropriate amount of protein extraction buffer was added to each sample. Low-temperature, noncontact ultrasonication was performed for 10 min, and the sample was subsequently centrifuged at 1200 × g for 10 min. The supernatant was used to construct the protein solution. The dilution buffer and reducing agent were added to the protein solution. The samples were incubated at 55 °C for 30 min to reduce the protein concentration. Alkylation reagent was added, and the mixture was incubated at room temperature in the dark for 30 min. Then, digestion buffer was added, and the mixture was incubated at 37 °C for 16 h. Finally, acidification buffer was added, and the mixture was incubated at 45 °C for 30 min to obtain the peptide sample. Peptide desalting and quantification The digested peptide solution was aliquoted into low-binding microcentrifuge tubes, which were then placed in a vacuum centrifugal concentrator (Huamei Biochemical Instrument Factory, Jiangsu) for continuous processing at 120 ± 10 min until dehydration was complete; the dried peptides were resuspended in 50 µL of mass spectrometry-grade aqueous solution containing 0.1% trifluoroacetic acid (TFA). The mixture was vortexed vigorously for 60 s, followed by ultrasonic treatment for 3 × 1 min (with ice bath intervals) to fully dissolve the peptide aggregates, desalted using C18 StageTip desalting columns, and then concentrated to dryness using a vacuum concentrator. Finally, the proteins were quantified by UV spectrophotometry using a Nanodrop One instrument (Thermo Scientific, USA). DIA Mass spectrometry detection and bioinformatics analysis Equal amounts of peptide segments were dissolved in mass spectrometry sample buffer for DIA analysis. Peptide separation was performed using a Vanquish Neo chromatograph (Thermo Fisher Scientific, USA) with a uPAC high-throughput column (75 μm × 5.5 cm), with mobile phase A being an aqueous solution containing 2% acetonitrile and 0.1% formic acid and mobile phase B being an aqueous solution containing 80% acetonitrile and 0.1% formic acid. Chromatographic separation lasted 8 min. Mass spectrometry data acquisition was performed using a Bruker timsTOF Ultra2 ion mobility spectrometry system. Peptide separation was achieved via nanoElute UHPLC ultrahigh-performance nanolitre liquid chromatography (equipped with a C18 reverse-phase column, 75 μm × 25 cm, 1.6 μm). The mass spectrometer was operated in DIA mode with positive ion detection and an ion source voltage of 4.5 kV. The mass spectrometer scan range was 100 ~ 1700 m/z. The raw data were searched and analyzed using Spectronaut 17 software against the UniProt database (species: Schistocephalus solidus, source: https://www.uniprot.org/proteomes/up000275846). The filtering criteria were strictly defined as follows: at least 6 unique peptides per protein were selected as quantitative features, and for each peptide, 3 high-response fragment ions (m/z > 300 and signal-to-noise ratio > 10) were prioritized for peak area integration. The quality control system included dual false discovery rate filtering (protein-level FDR ≤ 0.01, peptide-level FDR ≤ 0.01), a peptide confidence threshold ≥ 99%, and a mass deviation window ≤ 75 ppm for the extracted ion chromatogram (XIC). During data preprocessing, peptides with shared assignments or post-translational modifications were dynamically excluded. The ion current intensity was normalized across samples using the MaxLFQ algorithm. Relative protein abundance was calculated by weighting peak areas on the basis of the top three most abundant fragment ions. A local regression model was applied to correct for the effects of retention time drift on quantitative accuracy. Functional annotation analysis of the identified proteins was performed using UniProt (https://www.uniprot.org). Differentially expressed proteins were subjected to GO and KEGG enrichment analyses, protein interaction network analysis, and iPath metabolic pathway analysis. High-throughput sequencing analysis of miRNAs in plerocercoid EVs Total RNA was extracted from the EVs of S. mansoni plerocercoids using the TRIzol method, with 200 µL of EVs used per extraction. RNA sequencing libraries were constructed using the Illumina TruSeq Small RNA Library Prep Kit, with the experimental workflow strictly adhering to the principles of three biological replicates. Subsequently, library construction and sequencing were performed on the NovaSeq X Plus platform. Statistical methods were employed to assess the sequencing quality of raw sample data, including A/T/G/C base content, quality, and error rate distribution statistics, were applied to assess the quality of the raw sequencing data. The quality-controlled reads were aligned against the reference genome (species: Spirometra_erinaceieuropaei, gene version: GCA_902702965.1, source: https://www.ncbi.nlm.nih.gov/assembly/GCA_902702965.1) using Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml) to obtain mapped reads for subsequent known miRNA identification, novel miRNA prediction, and expression level calculation. Reads aligned to the reference genome were first compared to the mature and precursor miRNA sequences of the corresponding species in the miRBase 22.0 database (http://www.mirbase.org/) with one mismatch allowed; those that matched were identified as known miRNAs. Subsequently, based on the characteristic hairpin structure of miRNA precursors, reads that could not be aligned to either Rfam or miRBase were mapped to the reference genome. The flanking sequences were extracted and subjected to secondary structure prediction using the miRDeep2 software (https://www.mdc-berlin.de/content/mirdeep2-documentation). Novel miRNAs were then identified by filtering the prediction results based on features such as Dicer cleavage site information and minimum free energy. Target gene prediction for all the miRNAs was performed using miRanda (http://www.miranda.org/) and TargetScan (http://www.targetscan.org/). The functional annotation of target genes was conducted using Diamond (GO, https://github.com/bbuchfink/diamond), and genes were classified on the basis of biological processes, cellular components, and molecular functions. Genes were classified by pathway involvement or functional role using ID mapping (KEGG, https://www.genome.jp/kegg/). GO functional enrichment analysis was performed with GOatools (https://github.com/tanghaibao/GOatools), employing Fisher’s exact test based on a hypergeometric distribution model. KEGG pathway enrichment analysis was performed using KOBAS (http://kobas.cbi.pku.edu.cn/home.do). The same statistical model was employed to screen significant pathways within the KEGG database. Topological optimization analysis specifically targeted pathway hierarchical structures, and the Benjamini–Hochberg FDR correction method (AdjP ≤ 0.05) was applied strictly to determine the final significant pathways. Preparation of soluble worm proteins After the plerocercoids were dissected from KM mice, they were washed thoroughly with sterile PBS. Then, 20 mg of worm tissue was placed into a centrifuge tube containing 100 µL of PBS buffer, supplemented with PMSF (Solarbio, Beijing) and three grinding beads. Subsequently, the tube was placed in a tissue homogenizer (Servicebio, Wuhan) and homogenized at 60 Hz for 60 s. Following homogenization, the solution in the tube was subjected to sonication until it became clear. The clarified tissue lysate was then centrifuged at 12,000 g for 20 min at 4 °C. The supernatant was collected and stored at −80 °C for future use. Preparation of immune serum A total of 12 female Balb/c mice (4–6 weeks old) purchased from Henan Experimental Animal Center were randomly divided into three groups for immunization: the EVs group (EVs + adjuvant), the soluble worm proteins group (Soluble worm proteins + adjuvant), and the PBS group (PBS + adjuvant), with n = 4 per group. Each mouse received 20 µg of antigen per immunization, which was administered via multipoint subcutaneous injection on Days 1, 14, and 28. The antigens were emulsified 1:1 (v/v) with adjuvant prior to injection. The first immunization used Freund’s complete adjuvant, while the second and third immunizations used Freund’s incomplete adjuvant. Blood samples were collected from all groups of mice at the following time points: pre-immunization (blank serum), 7 days after the first immunization, and 7 days after the second immunization (via tail vein bleeding). Two weeks after the third immunization, systemic peripheral blood was collected. In addition, four additional Balb/c mice of the same type were designated as the infection serum group. These mice were orally administered plerocercoids (3 plerocercoids per mouse) to establish a persistent infection for six weeks. Subsequently, peripheral blood was collected from these mice via systemic sampling to prepare infection serum. Finally, the collected blood was allowed to stand at 37 °C for 2 h, followed by centrifugation at 3000 rpm for 15 min. The clear, upper serum layer was collected, aliquoted, and stored at −80 °C for subsequent use in Western blot and enzyme-linked immunosorbent assay (ELISA) analyses. Analysis of the antigenicity of immune serum Western blot analysis was performed on EVs and soluble worm proteins separately.The primary antibodies used were: sera from mice after the final immunization, infection serum, and sera from healthy mice (all diluted at 1:100). The secondary antibody was HRP-conjugated rabbit anti-mouse IgG (diluted at 1:5000). Color development was finally carried out using DAB chromogenic substrate. Enzyme-linked immunosorbent assay (ELISA) Changes in specific total IgG, IgG1, IgG2a, and IgM antibody levels against the corresponding antigens in each group of serum samples were measured using indirect ELISA. Plerocercoids-derived EVs were diluted in coating buffer and aliquoted into 96-well microplates at 100 µL/well, followed by static incubation at 4 °C for 12 h. After coating, plates were washed three times with phosphate-buffered saline containing 0.05% Tween-20 (PBST), each time with 5-min immersion and agitation to remove non-specifically adsorbed antigens. The blocking solution (5% skim milk in PBS) was sterilized through a 0.22 μm filter and added at 200 µL/well to antigen-coated plates, followed by 2 h of continuous blocking at 37 °C with gentle shaking. Immune sera from immunized mice were used as primary antibodies, diluted 1:100 in PBST, aliquoted at 100 µL/well, and incubated for 2 h at 37 °C with shaking. After washing, HRP-conjugated rabbit anti-mouse IgG, IgG1, IgG2a, and IgM secondary antibodies were diluted to 1:5000 in PBST, added at 100 µL/well, and incubated statically at 37 °C for 1 h. To thoroughly remove unbound secondary antibodies, plates were subjected to three rigorous PBST washes. Freshly prepared TMB substrate was then added for color development. The reaction was terminated by adding 50 µL of 2M H2SO4 per well. Within 30 min after termination, absorbance was measured at 450 nm using a SpectraMax M5 microplate reader (Molecular Devices, USA). Cytokine levels of IL-4, IL-10, IL-12, and IFN-γ in serum samples were measured using ELISA kits from Jonlnbio (jonlnbio, shanghai). The relevant information is as follows: the detection range of the IL-4 assay kit is 3.12–200 pg/mL, with a sensitivity of 1.67 pg/mL; the detection range of the IL-10 assay kit is 3.12–200 pg/mL, with a sensitivity of 1.45 pg/mL; the detection range of the IL-12 assay kit is 15.6–1000 pg/mL, with a sensitivity of 7.6 pg/mL; the detection range of the IFN-γ assay kit is 3.12–200 pg/mL, with a sensitivity of 2.13 pg/mL. The specific steps are as follows: the standard powder was centrifuged at 1000 × g, reconstituted with 1 mL universal antibody diluent, and allowed to stand for 20 min for complete dissolution. The 100× concentrated biotinylated antibody and HRP conjugate were then diluted to working concentration (1×) using universal antibody diluent. Serially diluted standards (8 gradients) and test samples were added at 100 µL/well to pre-coated 96-well plates and incubated at 37 °C for 1 h. After washing, 100 µL/well of biotinylated antibody working solution was immediately added and incubated at 37 °C for 1 h. Following another wash cycle, 100 µL/well of HRP conjugate working solution was added and incubated at 37 °C for 30 min. After 5 wash cycles, 90 µL/well of TMB substrate was added for color development. The reaction was terminated with H2SO4, and OD values were immediately measured at 450 nm using a microplate reader. Sample concentrations were calculated by fitting a standard curve using a four-parameter logistic regression model. Statistical analysis All results in this experiment are presented as mean ± standard deviation. Statistical analyses were performed using GraphPad Prism 9 for Windows. Two-way analysis of variance (ANOVA) was used to compare statistical differences between different groups and time points. The Bonferroni multiple comparison test was used to describe the statistical analysis. P‑values are indicated as *P < 0.0332, **P < 0.0021, ***P < 0.0002, ****P < 0.0001. Results EVs Identification TEM revealed that the EVs isolated from S. mansoni plerocercoids appeared as round or oval-shaped vesicles with a double phospholipid membrane, averaging 80–150 nm in diameter, which is consistent with the structural characteristics of EVs (Fig. 2a). Furthermore, western blot analysis using antibodies against HSP70, β-Actin, TSG101, HSP90, and CD81 revealed clear bands for EVs from S. mansoni plerocercoids. In the detection of the CD81 marker protein, two degradation bands with lower molecular weights were observed. This phenomenon may be related to protein degradation during the preparation and freeze-thaw cycles of EVs, which is a common occurrence (Fig. 2b). NTA further revealed that the average particle size of the collected EVs was 119.9 nm, which is consistent with the range of diameters of EVs secreted by parasites, with a sample concentration of 4.4 × 1011 vesicles per millilitre (Supplementary Table S1). Identification of plerocercoid EVs by TEM and western blot. (a) TEM image; red arrows indicate EVs in the field of view. (b) Western blot image. M: Protein Marker; EVs: Extracellular Vesicles. The loading amounts were normalized based on protein quantification using the BCA assay EVs DIA Microproteomics analysis DIA microproteomic analysis was performed on plerocercoids-derived EVs. A total of 11,971 peptides were identified from three replicate samples, among which 897, 1,224, 412, and 230 corresponded to single-peptide, 2 ~ 5 peptide, 6 ~ 10 peptide, and ≥ 11 peptide, respectively (Fig. 3a). The lengths of the identified peptides were predominantly between 7 and 16 amino acids, with a maximum length of up to 44 amino acids (Fig. 3b). Alignment of the 11,971 peptides against the UniProt database revealed 2,729 proteins, whose molecular weights were predominantly between 1 and 181 kDa (Fig. 3c). Furthermore, among all the identified proteins, 14 (0.52%) exhibited known protein’s sequence coverage greater than 60%, 102 (3.74%) showed 40%~60% coverage, 421 (15.43%) had 20%~40% coverage, 649 (23.78%) demonstrated 10%~20% coverage, 666 (24.40%) displayed 5%~10% coverage, 805 (29.50%) possessed 1%–5% coverage, and 72 (2.64%) presented less than 1% coverage. (Fig. 3d). Venn analysis of the three replicate samples revealed that all 2,729 proteins were expressed in all three replicates, indicating good reproducibility of the sequencing results (Fig. 3e). Additionally, we listed the top 20 proteins by peptide count among the 2,729 proteins (Supplementary Table S2). Peptides and proteins identified in EVs. (a) Distribution of peptide counts. (b) Distribution of peptide lengths. (c) Distribution of protein molecular weights. (d) Distribution of protein coverage. The coverage range denotes the proportion of known amino acid sequences within the target protein that were identified. Each sector represents the percentage of proteins within a specific coverage range. The data outside the sectors indicate the following: before the colon, the coverage range percentage; after the colon, the proportion of proteins within this range. The larger the sector area is, the greater the number of proteins in that coverage range. The legend corresponds to different coverage range intervals, with the first interval including 1% and the remaining intervals being open closed. (e) Venn diagram of proteins from three plerocercoid EVs samples Multidimensional functional annotation analysis was performed on 2,729 identified proteins. Among these, 2,416 proteins (88.5% coverage rate) were successfully annotated in the GO database; 1,957 proteins (71.7%) matched the KEGG metabolic pathway database; 2,390 proteins (87.6%) were annotated in the EggNOG homologous protein cluster database; and the Pfam protein domain database identified 2346 proteins (86.0%). Notably, subcellular localization information was obtained for all the identified proteins (Fig. 4a). In the EggNOG database, major annotations included intracellular transport, secretion and vesicular transport, and posttranslational modifications (Fig. 4b). GO classification revealed that 1,110 proteins in biological process (BP) were annotated for cellular process, 1,450 proteins in cellular component (CC) were annotated for cellular anatomical entity, and 1,252 proteins in molecular function (MF) were annotated for binding (Fig. 4c). Pfam analysis indicated that the identified proteins were primarily annotated for collagen, WD40, Pkinase, and others (Supplementary Fig. S1). Subcellular localization statistics revealed 1,888 proteins annotated as cytoplasmic (Supplementary Fig. S2). KEGG functional annotation revealed the most annotated pathways in each category: 312 proteins in environmental information processing (EIP) were associated with signal transduction; 247 proteins in human disease (HD) were associated with infectious disease (bacteria); 241 proteins in cellular processes (CP) were associated with transport and catabolism; 173 proteins in organismal systems (OS) were associated with the endocrine system; 166 proteins in genetic information processing (GIP) were associated with folding, sorting and degradation; and 139 proteins in metabolism (M) were associated with carbohydrate metabolism (Fig. 4d). Further statistical analysis of key pathways revealed that 162 proteins were associated with multiple neurodegenerative disease pathways, 132 proteins were associated with the amyotrophic lateral sclerosis pathway, and 130 proteins were associated with the Alzheimer disease pathway (Supplementary Fig. S3). Annotation of the EVs proteome. (a) Bar plot of the annotation results from various databases. (b) Bar plot of EggNOG classification statistics. (c) Bar plot of the GO classification statistics. (d) Statistics of KEGG pathway functions High-throughput sequencing of EVs miRNAs High-throughput sequencing of sRNA in EVs generated 31.68 M raw reads. After quality control, clean reads were obtained for each sample, with base quality scores of 99% and 99.9% (Q20 and Q30) exceeding 99.37% and 96.26%, respectively, and a GC content of 54.71%. Subsequently, clean reads were further filtered to obtain reads with lengths between 18 and 32 nt, which were defined as useful reads for subsequent analysis. (Supplementary Table S3). Effective reads from each sample were aligned against the reference genome (Spirometra erinaceieuropaei, gene version: GCA_902702965.1). A total of 37 known miRNAs and 118 novel miRNAs were identified, with lengths predominantly concentrated between 20 ~ 24 nt, which is consistent with the typical miRNA size range. Here, we present 20 known miRNA sequences that potentially play important roles in the parasite (Supplementary Table S4). Read distribution statistics revealed that the majority of the reads mapped to the positive strand of scaffold CACRXP010000015.1 and the negative strands of scaffolds CACRXP010000057.1 and CACRXP010000633.1 (Fig. 5a). The expression levels of known and novel miRNAs were normalized using TPM (TPM = miR_readscounts × 1000000 ÷ librarysize, librarysize refers to the total read counts mapped to miRNAs). The results revealed consistent miRNA expression patterns across samples, with highly concentrated expression regions exhibiting high similarity (Fig. 5b). Venn analysis of expression matrices revealed that 113 miRNAs (72.9%) were coexpressed across all three samples, while sample-specific miRNAs were relatively scarce (Fig. 5c). Furthermore, a total of 1,703,112 reads from S. mansoni EVs were mapped to various types of sRNA, among which 43,215 reads (approximately 2.54%) corresponded to miRNAs. Additionally, rRNAs accounted for 64.24%, tRNAs for 10.82%, and other categories for 22.40%. (Fig. 5d). Analysis of EVs miRNA sequencing results. (a) scaffolds read distribution statistics plot. The X-axis represents the IDs of the top 10 scaffolds by abundance; the Y-axis represents the number of reads mapped to the positive strand (above the X-axis) and the negative strand (below the X-axis) of the corresponding scaffold. (b) miRNA expression density plot. The X-axis represents log10(TPM + 1), where a higher value indicates higher miRNA expression; the Y-axis represents the density of miRNAs, i.e., the total number of miRNAs corresponding to the expression level on the X-axis. Each colour in the plot represents a sample. The total probability is equal to 1, meaning that the area under each curve is normalized to 1. The peak of the density curve indicates the region where the miRNA expression is most concentrated for the entire sample. (c) Venn diagram of intersections between samples. Circles of different colours represent miRNAs filtered on the basis of expression levels in each sample; the numbers indicate the counts of miRNAs that are common or unique to different samples/groups. (d) sRNA statistics plot. The outer ring divides all sRNA sequence annotation results into four major categories: miRNA, sncRNA, genome, and unknown.The inner ring displays the proportional distribution of specific RNA subtypes within each corresponding major category. Among these: the miRNA category comprises known_miRNA and novel_miRNA; the sncRNA category includes tRNA, rRNA, snRNA, and snoRNA; the Genome category covers sequences derived from repbase, exon, and intron; Unknown represents the proportion of unannotated small RNA sequences with no functional information Target prediction analysis of miRNAs revealed that a total of 6,050 target genes were predicted for 155 miRNAs, among which 6,018 were annotated in the NR database, 3,125 in Swiss-Prot, 3,584 in Pfam, and 1,958 in matched KEGG pathways. A total of 4,627 genes were annotated in the GO database, and 4,767 were annotated in EggNOG (Fig. 6a). GO enrichment analysis revealed that miRNA target genes in BP were enriched primarily in DNA integration, cellular macromolecule metabolic processes, heterocycle metabolic processes, and others. In MF, enrichment was primarily observed in aspartic-type peptidase activity and aspartic-type endopeptidase activity. In the CC category, enrichment was primarily observed for clathrin-coated vesicle membranes, coated vesicle membranes, and transcription elongation factor complexes. Notably, egr-miR-133-3p was significantly enriched in DNA integration, DNA metabolic processes, nucleic acid metabolic processes, and cellular macromolecule metabolic processes, suggesting its potential involvement in cellular proliferation and differentiation, as well as metabolic adaptation in the worm body or host energy balance (Fig. 6b). KEGG pathway enrichment analysis revealed that target genes were enriched primarily in pathways related to apoptosis–fly, cholesterol metabolism, and neuroactive ligand–receptor interactions. Notably, CACRXP010000588.1_16126 and egr-miR-125-5p were significantly enriched in all these pathways, suggesting similar functional roles and potential importance in regulating cell death and inflammatory responses (Fig. 6c). Analysis of EVs miRNA target genes. (a) Statistical plot of target gene functional annotation. The X-axis represents the names of the various databases; the Y-axis represents the number of annotated target genes in each database. (b) GO enrichment analysis of target genes. (c) KEGG enrichment analysis of target genes Serum antibody levels and cytokine content in EVs-immunized mice Western blot results revealed that the EVs-immune serum specifically recognized a single band at approximately 25 kDa, while the infection serum recognized multiple bands. Similarly, both the worm soluble protein-immunized serum and the infection serum yielded consistent results, recognizing multiple bands, whereas the normal mouse serum did not recognize any bands (Supplementary Fig. S4). To assess antibody levels in immune serum, we used ELISA to monitor changes in IgG, IgM, IgG1, and IgG2a antibodies over time. EVs and soluble worm proteins can induce the occurrence of humoral immunity. The IgG levels in both the EVs group and the soluble worm protein group increased after each immunization, showing a significant difference compared to the PBS group (P < 0.0001) (Fig. 7a). Both EVs and soluble worm proteins induced high levels of IgM antibodies in mice. In the EVs group, IgM levels decreased slightly after the first immunization but then increased rapidly following the third immunization, peaking at a significantly higher level (P < 0.0001). Similarly, serum IgM levels in the soluble worm proteins group were also significantly elevated (P < 0.0001) (Fig. 7b). Specific IgG1 antibodies in the EVs group increased slowly after the first immunization, rose rapidly after the second immunization, and peaked after the third immunization (P < 0.0002); Similarly, in the soluble worm proteins group, IgM levels showed a comparable pattern, with a significant increase observed after the third immunization (P < 0.0021).(Fig. 7c). The EVs group showed high levels of IgG2a, which increased rapidly after the second immunization and peaked after the third immunization (P < 0.0021). A similar pattern was observed in the soluble worm protein-immunized group (P < 0.0001), indicating that both EVs and soluble worm proteins may activate a mixed Th1/Th2 immune response(Fig. 7d). Furthermore, the IgG1 level in the EVs group was higher than the IgG2a level, whereas in the soluble worm protein group, the IgG1 level was lower than the IgG2a level (Fig. 7e). Moreover, the IgG2a/IgG1 ratio in the EVs group showed an upward trend but remained < 1.0, while the ratio in the soluble worm protein group exhibited a “decrease-rebound” pattern with a final value > 2.0 (Fig. 7f). These results confirm that EVs induced a mixed Th1/Th2 immune response dominated by Th1 pathway activation in mice, whereas the soluble worm proteins induced a predominantly Th1-type cellular immune response. Additionally, the levels of the cytokines IL-4, IL-10, IL-12, and IFN-γ in mouse serum were further detected before and after immunization using an enzyme-linked immunosorbent assay (ELISA). The results demonstrated that EVs and soluble worm proteins can induce a cellular immune response in mice. Compared to the PBS group, the EVs group showed significant differences in serum IL-10 levels before immunization and after the final immunization (P < 0.0332), and the levels of IL-4, IL-12, and IFN-γ were also elevated. In the soluble worm proteins group, although the levels of IL-4, IL-10, IL-12, and IFN-γ increased after the last immunization compared with pre-immunization, the differences were not statistically significant. These results indicate that Sparganum EVs can mediate immunomodulation through IL-10, whereas soluble worm proteins lack this function. Furthermore, the increase in serum IFN-γ levels after the final immunization in the EVs group was significantly greater than that of IL-4. Combined with the aforementioned changes in the IgG2a/IgG1 ratio, it can be concluded that plerocercoid-derived EVs induce a mixed Th1/Th2 immune response in mice, predominantly biased toward, whereas the soluble worm proteins induce an immune response predominantly characterized by Th1-type cellular immunity (Fig. 7g). Measurement of antibody levels and cytokine content in immune serum against plerocercoid EVs and soluble worm proteins. (a) IgG antibody levels. (b) IgM antibody levels. (c) IgG1 antibody levels. (d) IgG2a antibody levels. (e) Comparison of IgG1 and IgG2a antibody levels in the EVs group and soluble worm proteins; (f) Trend of IgG2a/IgG1 ratio in the EVs group and soluble worm proteins; (g) Measurement of cytokine levels. Data were evaluated using Bonferroni’s multiple comparison test. *P < 0.0332, **P < 0.0021, ***P < 0.0002, ****P < 0.0001 Discussion In this study, EVs secreted by the plerocercoid of S. mansoni were successfully identified through transmission electron microscopy, western blot, and nanoparticle tracking analysis. The composition of these EVs was further detailed through microproteinomics technology. The results revealed that S. mansoni plerocercoid EVs possess a typical bilayer phospholipid membrane structure, with diameters predominantly distributed between 80 and 150 nm. Among previously reported parasitic EVs, the diameter distributions vary considerably: those from E. multilocularis range from 40 to 110 nm (Liu et al. 2023); those from Sparganum solidum range from 100 to 160 nm (Mazanec et al. 2023); Trichinella spiralis EVs exhibit cup-shaped circular structures with diameters ranging from 30 to 80 nm (Kosanović et al. 2019); and Schistosoma japonicum EVs span 100 to 400 nm in diameter (Liu et al. 2019). Despite size variations among EVs from different parasite species, they all exhibit the following general characteristics of parasitic EVs: a bilayer lipid structure, bioactive molecules, including proteins, nucleic acids, and lipids; and functional mediation of parasite-parasite and parasite-host communication. Western blot analysis revealed the expression of EVs marker proteins, including HSP70, TSG101, and CD81, in S. mansoni plerocercoid EVs, which is consistent with the findings of Kowal et al. Among these proteins, HSP70 serves as a universal vesicle marker, and TSG101 is an exosome-specific marker, whereas CD63, CD9, and CD81 are typical surface markers for small EVs (Kowal et al. 2016). Furthermore, Liu et al. detected CD63 and TSG101 in E. multilocularis EVs, whereas Pushpamithran et al. confirmed the presence of marker proteins including CD63 and CD81 in Ascaris lumbricoides EVs (Liu et al. 2023; Pushpamithran and Blomgran 2024), further validating the accuracy of our identified plerocercoid EVs identification. DIA technology features high throughput, high reproducibility, high sensitivity, broad application compatibility, and robust computational analysis capabilities. It plays a significant role in proteomics and quantitative research d(Lou and Shui 2024). In this study, DIA identified a total of 2,729 proteins. In comparison, Gao X et al. identified 753 proteins in T. spiralis EVs using liquid chromatography–tandem mass spectrometry (LC–MS/MS) (Gao X et al. 2022), while Wang et al. identified only 561 proteins and 446 lipids in Caenorhabditis elegans EVs (Wang et al. 2023). Thus, compared with traditional LC–MS/MS methods, DIA provides more comprehensive peptide coverage and effectively identifies low-abundance proteins, and thereby significantly enhance the capability to identify proteins in samplessignificantly. To characterize the functions of the 2,729 proteins identified in this study, we performed GO functional and KEGG pathway annotations. GO enrichment analysis revealed that these proteins were annotated in cellular processes, cellular structural entities, binding, and catalytic activity. KEGG functional enrichment analysis revealed that these proteins are associated with signal transduction, bacterial infectious diseases, transport and catabolism, carbohydrate metabolism, the endocrine system, and folding, classification, and degradation. These findings align with those reported by Coakley et al. (Coakley et al. 2015), suggesting that parasite EVs may play a crucial role in regulating host immune responses and intercellular communication. Pfam analysis revealed that the identified proteins were predominantly annotated to Collagen, WD40, Pkinase, and EF-hand-1 domains. Among these domains, the WD40 domain plays a crucial role in signal transduction, protein degradation, and apoptosis and may function as a scaffold for protein–protein interactions (Hu et al. 2023). In C. elegans, the WD40 domain is crucial for lifespan extension and exosome secretion (Yang et al. 2024). In this study, small RNAs in plerocercoid EVs were analysed using high-throughput miRNA sequencing. The results revealed that plerocercoid EVs contain miRNAs, sncRNAs, genome, and unknown sequences. Among these, the proportion of miRNAs was relatively low, a common phenomenon observed in small RNA sequencing of parasitic EVs (Du et al. 2020; Zhu et al. 2016). This highlights that parasitic EVs may selectively package a diverse repertoire of small RNAs, extending beyond just miRNAs. Specifically, miRNAs can function as effector molecules to regulate host gene transcription through multi-target synergistic effects, thereby helping to establish a microenvironment conducive to parasite survival (Zhong et al. 2024). sncRNAs (including tRNA, rRNA, snRNA, and snoRNA) may be involved in parasite growth, development, metabolism, and protein transcription/translation. Genome-derived small RNAs (Repbase, Exon, and Intron) could participate in parasite–host interactions via mechanisms such as epigenetic regulation, translational interference, and spliceosome hijacking (Faulkner et al. 2009; Valadi et al. 2007; Zhang et al. 2013). Meanwhile, the presence of unknown suggests that plerocercoid EVs may harbor novel small RNAs with unknown functions or species-specific sequences, providing valuable clues for the future discovery of new parasitic effector molecules. Additionally, within the miRNA fraction, we identified 37 known miRNAs and 118 novel miRNAs. Compared with previously reported miRNA profiles in EVs from Taenia asiatica (20 known miRNAs, 28 novel miRNAs) (Liang et al. 2019) and Trichinella spiralis (10 known miRNAs, 54 novel miRNAs) (Wu et al. 2022), the number of miRNAs identified in this study, particularly the novel miRNAs, is notably higher. This suggests a high diversity of miRNAs in plerocercoid EVs. More importantly, cross-species comparison reveals that only a small fraction of miRNAs are shared, while the vast majority are species-specific. Therefore, these unique miRNAs (especially the newly predicted ones) may target and regulate specific host physiological pathways, providing a new set of candidate molecules for further exploration of the pathogenic mechanisms of plerocercoid. Thus, compared with the number of miRNAs identified in other parasitic EVs studies, the greater number detected in this study may be attributed to interspecies difference. Furthermore, studies have demonstrated that egr-miR-277a-3p promotes dendritic cell maturation and differentiation by regulating the NF-κB signaling pathway, thereby inducing a Th1-type immune response (Zhang et al. 2022), and that egr-miR-10a-5p plays a critical role in the growth and development of parasites (Faridi et al. 2021). Based on the functional analysis of miRNA in the above studies, we hypothesize that among the 37 known miRNAs in S. mansoni plerocercoid EVs, several play crucial roles in the growth and development of the plerocercoid as well as in host immune regulation. For the 118 novel miRNAs, GO enrichment analysis revealed that their target genes were enriched primarily in processes such as DNA integration, macromolecular metabolism, and nucleic acid metabolism. KEGG pathway enrichment analysis indicated that their target genes were predominantly enriched in apoptosis, cholesterol metabolism, and cAMP signalling pathways. Thus, these novel miRNA target genes may influence host immune responses by regulating pathways such as apoptosis, cholesterol metabolism, and neuroactive ligand–receptor interactions. Furthermore, we found that egr-miR-133-3p was significantly enriched in pathways related to DNA integration, DNA metabolism, nucleic acid metabolism, and macromolecular metabolism. Previous studies have indicated that miR-133-3p promotes the production of inflammatory cytokines, helping to regulate the host inflammatory response, and plays a crucial role in regulating cell proliferation and apoptosis (Sun et al. 2022). Additionally, egr-miR-125-5p was significantly enriched in pathways related to apoptosis, cholesterol metabolism, and neuroactive ligand-receptor interactions. Research has indicated that miR-125-5p modulates macrophage inflammatory responses through the JAK1/STAT3 and NF-κB pathways and plays a crucial role in inhibiting apoptosis (Chen and Jiang 2022). However, research on egr-miR-133-3p and egr-miR-125-5p in the field of parasitology remains unexplored. Therefore, future studies should further investigate the potential mechanisms and functions of parasitic miRNAs, laying the foundation for the discovery of novel diagnostic and therapeutic approaches as well as vaccines. This study also analysed the immunological properties of plerocercoid EVs and found that they can elicit a mixed immune response in the host, predominantly polarized toward the Th1-type. Western blot analysis revealed that the EVs contained multiple antigenic proteins within the 20 ~ 100 kDa range. Among these proteins, the 25 kDa protein exhibited stable immunogenicity after the three immunizations, suggesting its crucial role in activating the host immune system and modulating the host immune response. It is noteworthy that the differences in Western blot results between the infection serum and the EVs-immune serum suggest that EVs may carry certain parasite-specific antigens. This characteristic resembles the antigen presentation mechanism observed in Plasmodium falciparum EVs (Mantel et al. 2013). Analysis of humoral immunity revealed significantly elevated IgG antibody levels in the EVs group, with a markedly higher IgG2a/IgG1 ratio than in the control group, indicating a Th1-dominant immune response. With respect to cellular immune responses, IFN-γ levels significantly increased alongside moderate increases in IL-4 and IL-12 levels, confirming a mixed Th1/Th2 response pattern. This phenomenon mirrors findings in studies of E. granulosus EVs (Nicolao et al. 2019). Furthermore, compared with the strong Th1 response induced by Toxoplasma gondii EVs (Wowk et al. 2017), the significant increase in IL-10 suggests that S. mansoni plerocercoid EVs may simultaneously activate immunoregulatory pathways. Additionally, the rapid IgM response observed in this study aligns with the acute-phase response pattern reported in studies of Trypanosoma evansii EVs (Cestari et al. 2012). Plerocercoid EVs can simultaneously activate Th1 and Th2 pathways, although Th1 polarization is more pronounced. This difference may be related to the antigenic components carried by EVs. For instance, the 25 kDa protein detected in this study shares similarities with Leishmania GP63, which promotes Th1 polarization (Hassani et al. 2014). Future research should focus on identifying the key 25 kDa antigen and validating its protective efficacy in animal models. Furthermore, this study found that EVs and soluble worm proteins induced two distinct types of immune responses: EVs induced a mixed Th1/Th2 immune response dominated by Th1 in mice (with a significant increase in IL-10), whereas the soluble worm proteins induced an immune response predominantly characterized by Th1-type cellular immunity. This indicates that plerocercoids can actively retain host type Ⅰ cellular immune signals via EVs, but can limit their inflammatory and cytotoxic effects through IL-10, which aligns well with the biological strategy of parasites relying on immune evasion for long-term survival (Coakley et al. 2015). In contrast, although soluble worm proteins can induce a potent Th1 response, they lack regulatory components. However, due to the absence of plerocercoids infection group, it was not possible to further compare the differences in antibody and cytokine responses between EVs immunization, worm soluble proteins immunization, and the state of plerocercoids infection. This is a limitation of the present study, and future work could include an infection group to further refine the research on host-parasite immune interaction mechanisms. However, this study has not investigated the functional mechanisms of EVs, nor has the specific role of EVs in host-parasite interactions been elucidated. Future studies should employ in vitro and in vivo experiments to investigate how miRNAs in EVs regulate host immune responses and intercellular communication, particularly their roles in immune evasion and tissue invasion, thereby providing new theoretical foundations and potential targets for studying parasite-host interactions and developing prevention and control strategies. Conclusions In this study, EVs secreted by S. mansoni plerocercoids were successfully isolated and characterized. Through DIA microproteomics, 2,729 proteins were identified, with functional annotation revealing that EVs proteins were predominantly enriched in pathways such as intracellular transport/secretion, cellular processes, and signal transduction. Concurrently, high-throughput miRNA sequencing revealed 136 regulatory miRNAs, including 118 novel miRNAs, that may influence host immunity by modulating pathways such as cholesterol metabolism. Immunological analysis of EVs revealed the presence of a specific antigen of approximately 25 kDa, which activated a Th1/Th2 mixed immune response dominated by Th1 cells. This study integrated multi-omics data to comprehensively elucidate the biological characteristics of S. mansoni plerocercoid EVs, laying a foundation for further functional mechanism research. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 (DOCX 1.05 MB) Author contributions The study was designed by Xi Zhang. Experiments were performed by Xuan Xuan Song, Fei Gao, and Gu Jin Guan. Data analysis was completed by Xuan Xuan Song with the assistance of Xi Zhang and Yan Yan Zhou. The manuscript was written and revised by Xi Zhang, Yan Yan Zhou, and Xuan Xuan Song. All authors read and approved the final manuscript. Funding This work was supported by National Key R&D Program of China (2024YFE0199100), Fundamental Research Project of key scientific research in Henan Province (24ZX003) and National Natural Science Foundation of China (81971956). Data availability All relevant data supporting the conclusions of this study are included in the main text and the related supplementary materials of this article. Declarations Ethics approval All experimental methods in this study comply with relevant guidelines and regulations, and do not involve human experiments. The animal experiments in this study were carried out on the basis of National Guidelines for Experimental Animal Welfare of China. All animal experimental protocols were approved by the Life Science Ethics Committee of Zhengzhou University (No. ZZUIRB GZR 2023 − 0115). Consent for publication All the authors consent to publication of this. Consent to participate Not applicable. Clinical trial number Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Yan Yan Zhou, Email: zhouyy2025@zzu.edu.cn. Xi Zhang, Email: zhangxi@zzu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1 (DOCX 1.05 MB) Data Availability Statement All relevant data supporting the conclusions of this study are included in the main text and the related supplementary materials of this article.